What is safety pharmacology?

• A. The discipline that evaluates the economic impact of drug safety
• B. The discipline that studies pharmacokinetics in animals
• C. The discipline that seeks to predict whether a drug, if administered to human (or animal) populations, is likely to be found unsafe
• D. The discipline focused on post-approval risk communication

Answer: (C)

Safety pharmacology focuses on evaluating a drug’s potential to cause adverse effects on vital body systems in preclinical testing so we can predict safety in humans. It involves targeted studies on major organ systems—especially cardiovascular, respiratory, and central nervous system functions—using in vitro and in vivo models to identify possible risks such as heart rhythm problems, breathing or CNS effects, and other systemic issues at expected exposure levels. The aim is to flag safety concerns early and guide dose selection, study design, and risk mitigation before substantial human use. This field isn’t about the economic impact of safety, nor is it limited to pharmacokinetics, and it isn’t about post-approval risk communication; those areas relate to pharmacoeconomics, pharmacokinetics-focused studies, and pharmacovigilance, respectively.